VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 174 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $235,046 | -39.4% | 31,806 | -18.9% | 0.01% | -41.2% |
| Q3 2022 | $388,000 | -9.8% | 39,225 | -0.6% | 0.02% | -5.6% |
| Q2 2022 | $430,000 | -1.1% | 39,454 | +2.6% | 0.02% | 0.0% |
| Q1 2022 | $435,000 | -33.4% | 38,438 | -7.7% | 0.02% | -21.7% |
| Q4 2021 | $653,000 | -31.0% | 41,638 | -24.6% | 0.02% | -32.4% |
| Q3 2021 | $946,000 | -23.0% | 55,206 | -3.3% | 0.03% | -17.1% |
| Q2 2021 | $1,228,000 | +47.6% | 57,086 | +3.0% | 0.04% | +57.7% |
| Q1 2021 | $832,000 | +11.4% | 55,408 | -2.6% | 0.03% | +4.0% |
| Q4 2020 | $747,000 | – | 56,875 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |